ArticleEuropean heart journal. Case reports2025
Myocarditis or 'hot phase' of arrhythmogenic cardiomyopathy? A case series.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Multimodality Imaging in Myocarditis: Integrating Etiology, Diagnosis, and Risk Stratification.Current cardiology reports · 2026Review
- A Diagnostic Dilemma of Arrhythmogenic Cardiomyopathy Masquerading as Recurrent Myocarditis in a Pediatric Patient with aJournal of cardiovascular development and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Arrhythmogenic cardiomyopathy (ACM) is a genetic condition characterized by fibrofatty replacement of myocardial tissue, leading to arrhythmias and structural heart changes. Recent studies have identified an acute inflammatory phase, or 'hot phase', within the progression of ACM that presents with clinical features similar to myocarditis. This phase complicates the differentiation between ACM and myocarditis, posing a diagnostic challenge. Case summary: We present two cases of young male patients, both with mutations in the DSP and LMNA genes, who initially presented with symptoms of myocardial inflammation. Patient 1, a 23-year-old male, presented with pleuritic chest pain, elevated troponin, and imaging findings suggesting myocarditis. Cardiac magnetic resonance (CMR) revealed extensive subepicardial late gadolinium enhancement (LGE) in a non-ischaemic pattern. Genetic testing confirmed a likely pathogenic (LP) LMNA mutation. Patient 2, a 26-year-old male with family history of sudden cardiac death, presented similarly with chest pain and elevated biomarkers. His CMR showed intramural LGE, and genetic testing identified a LP DSP mutation. He underwent implantation of a subcutaneous defibrillator (ICD) due to arrhythmic risk. Discussion: This case series underscores the importance of recognizing the 'hot phase' of ACM, which can clinically mimic myocarditis. Cardiac magnetic resonance is crucial for differentiating these entities, while genetic testing confirms the diagnosis, offering prognostic information. Mutations in the LMNA and DSP genes, particularly associated with inflammation in ACM, require consideration of arrhythmia prevention strategies, such as ICD implantation. Multidisciplinary management and advanced imaging play essential roles in the care of these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.